Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

614
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
614
Hepatic Portal System01:21

Hepatic Portal System

1.5K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.5K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

86
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
86

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian Hospital.

Drug and alcohol review·2026
Same author

Corrigendum to: Factors associated with delayed diagnosis of hepatitis B in southeastern Sydney.

Public health research & practice·2026
Same author

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial.

JAMA psychiatry·2026
Same author

Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study.

The International journal on drug policy·2026
Same author

New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort study.

International journal of epidemiology·2026
Same author

Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis.

The International journal on drug policy·2026

関連する実験動画

Updated: Jul 15, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.2K

C型肝炎

Marianne Martinello1, Sunil S Solomon2, Norah A Terrault3

  • 1Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, Sydney, NSW, Australia; Department of Infectious Diseases, Prince of Wales Hospital, Sydney, NSW, Australia.

Lancet (London, England)
|September 23, 2023
PubMed
まとめ
この要約は機械生成です。

C型肝炎ウイルス (HCV) の排除には,スクリーニングの改善,治療へのアクセス,予防が必要です. 直接作用する抗ウイルス薬は希望を与えますが,より広範な公衆衛生戦略は2030年までに世界的なHCV撲滅に不可欠です.

さらに関連する動画

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

10.2K

関連する実験動画

Last Updated: Jul 15, 2025

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.2K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K
Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

10.2K

科学分野:

  • ウイルス学
  • ヘパトロジー
  • 公衆衛生

背景:

  • C型肝炎ウイルス (HCV) は肝臓の損傷,肝硬変,癌を引き起こす.
  • 2030年までに世界的なHCV撲滅が WHOの目標です
  • 何百万人も感染し,毎年死者が多い.

研究 の 目的:

  • 世界的にHCV感染の現状を見直す.
  • 直接作用する抗ウイルス薬 (DAA) の効果を強調する.
  • HCVの排除に必要な主要な戦略を特定する.

主な方法:

  • HCV 感染率と死亡率に関する疫学データのレビュー
  • 直接作用の抗ウイルス療法の臨床効果の評価
  • HCV制御のための公衆衛生介入の分析

主要な成果:

  • 直接作用する抗ウイルス薬は HCV治療に変化をもたらしました
  • 進展があったにも関わらず,世界的なHCVの負担は依然として大きい.
  • スクリーニング,ケアへのリンク,治療の範囲には大きなギャップがあります.

結論:

  • HCVの除去には 多面的なアプローチが必要です
  • スクリーニングの強化や 介護の連携や予防が不可欠です
  • 2030年の絶滅目標を達成するには 継続的な努力が必要です